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Abstract 14 
Bacterial conjugation, a mechanism of horizontal gene transfer, is the major means 15 
by which antibiotic resistance spreads among bacteria (1,2). Conjugative plasmids 16 
are transferred from one bacterium to another through a type IV secretion system 17 
(T4SS) in a form of single-stranded DNA covalently attached to a protein called 18 
relaxase. The relaxase is fully functional both in a donor cell (prior to conjugation) 19 
and recipient cell (after conjugation). Here we demonstrate that the protein substrate 20 
has to unfold for efficient translocation through the conjugative T4SS. Furthermore, 21 
we present various relaxase modifications that preserve the function of the relaxase 22 
but block substrate translocation. This study brings us a step closer to deciphering 23 
the complete mechanism of T4SS substrate translocation, vital for development of 24 
new therapies against multidrug-resistant pathogenic bacteria. 25 
 26 
 27 
Importance 28 
Conjugation is the principal means by which antibiotic resistance genes spread from 29 
one bacterium to another (1,2). During conjugation, a covalent complex of single-30 
stranded DNA and a protein termed relaxase is transported by a type IV secretion 31 
system. To date, it is not known whether the relaxase requires unfolding prior to 32 
transport. In this report, we use functional assays to monitor the transport of relaxase 33 
wild-type and variants containing unfolding-resistant domains and show that these 34 
domains reduce conjugation and protein transport dramatically. Mutations that lower 35 
the free energy of unfolding in these domains do not block translocation and can 36 
even promote it. We thus conclude that the unfolding of the protein substrate is 37 
required during transport.  38 
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Introduction 39 
Bacteria have evolved a diversity of specialized secretion systems that allows 40 
them to translocate macromolecules across the cell envelope (3). Among them, the 41 
type IV secretion system (T4SS) is the most versatile (4). T4SSs mediate the transfer 42 
of DNA and protein substrates across the cell envelopes. The largest and most 43 
widely distributed of the T4SS subfamilies are conjugation systems (5).   44 
Conjugation is a major mechanism of horizontal gene transfer (6,7). It is a 45 
process by which one bacterium, the donor, transfers genetic material to another 46 
bacterium, the recipient, in a contact-dependent manner (8). Thus, conjugation is the 47 
major means by which antibiotic resistance genes spread among bacterial 48 
populations (1,2). Conjugation is widely distributed among Gram-negative bacteria, 49 
Gram-positive bacteria, and even some archaea (9).  50 
Many plasmids and integrative and conjugative elements (ICEs), so-called 51 
“mobile elements”, undergo conjugation (10). Many of these mobile genetic elements 52 
are self-transmissible: they encode the entire machinery necessary for their transfer 53 
into recipient cells. Proteins necessary for conjugation assemble into two complexes: 54 
a DNA-processing complex called the relaxosome and a complex responsible for 55 
transfer, the T4SS. The relaxosome is an assembly of a protein called relaxase and 56 
a few accessory proteins that bind a specific DNA sequence called oriT (origin of 57 
transfer) to form a nucleo-protein complex (11). The T4SS is a large (3-4 58 
MegaDalton) protein complex consisting of a transport apparatus that spans the 59 
bacterial cell envelope (12), a pilus that extends from the cell surface (13) and 60 
mediates contact between cells (14), and a type IV coupling protein (T4CP) (15,16) 61 
that recruits the relaxosome to the secretion channel.  62 
The general mechanism of conjugation is still poorly understood but some 63 
steps are known (11,17). The relaxase encoded by a number of plasmids (but not all) 64 
is an enzyme that often carries two activities, a transesterase/nicking activity and a 65 
helicase activity. The transesterase nicks the plasmid DNA strand destined for 66 
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transfer (T-strand) at a specific position within oriT, called nic, and remains covalently 67 
attached through a catalytic tyrosine to the 5′ phosphate end of the cleaved strand. 68 
The relaxase and accessory proteins carry translocation signals for recruitment of the 69 
transfer intermediate to T4SS via T4CP. Upon contact with a recipient cell, the 70 
substrate - the relaxase covalently attached to the T-strand – is transported into the 71 
recipient cell in an ATPase-dependent manner. During the translocation process, the 72 
T-strand is unwound from its complementary strand by a second copy of the 73 
relaxase, the helicase activity of which motors the T-strand through the T4SS, 74 
presumably assisted by some of the T4SS ATPases (18). In the recipient cell, the 75 
relaxase molecule that has passed through the system may recircularize the T-76 
strand, and the complementary strand is synthesized (17).  77 
R388 is one of the best-studied conjugative plasmids that belong to a broad-78 
host-range group of plasmids (19,20). Proteins essential for conjugation are encoded 79 
within two separate gene clusters. One cluster contains oriT and genes encoding the 80 
accessory protein TrwA, the T4CP protein TrwB, and the relaxase TrwC, whereas 81 
the other cluster encodes eleven T4SS proteins, TrwN-TrwD, homologs of the VirB1-82 
VirB11 proteins of the prototypical T4SS from Agrobacterium tumefaciens, the 83 
VirB/D4 system (21,22). 84 
The TrwC relaxase is a 107 kDa protein composed of two domains: an N-85 
terminal transesterase (also termed “relaxase”) domain (approx. 1-300 residues) and 86 
a C-terminal helicase domain (approx. 300-966 residues). High-resolution crystal 87 
structures of TrwC relaxase domain in complex with oligonucleotides containing 88 
TrwC binding and/or nicking sites revealed details of DNA binding site recognition 89 
and nicking mechanism by TrwC (23,24). Nucleophilic attack of the nic site by the 90 
catalytic tyrosine, Tyr18 (25), generates a phosphotyrosine bond between the 91 
cleaved T-strand 5’ phosphate and the Tyr residue in the relaxase. The C-terminus of 92 
TrwC (residues 796-802) contains a translocation signal for recruitment by the T4SS 93 
machinery (26). The helicase domain contains a 5′–3′ helicase activity (27). Once in 94 
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the recipient cell, the helicase domain is thought to track 5′–3′ along the T-strand in 95 
order to position it correctly for the termination rejoining step (28). It is also thought to 96 
be responsible for the unwinding of the T-strand during conjugation. In this case, the 97 
T-strand unwinding TrwC molecule would have to be distinct from the translocated 98 
one (18).  99 
 The fact that the relaxase has to pass through the T4SS raises the question 100 
whether the relaxase is transported in a folded or unfolded state through the T4SS 101 
channel. Among other types of bacterial secretion systems, some are known to 102 
transport folded substrates (such as type 2 secretion systems (29) and chaperone-103 
usher pathway (30,31)), whereas some can translocate only unfolded substrates 104 
(e.g. type 1 secretion systems (32) and type 3 secretion systems (33,34)). The 105 
negative stain-electron microscopy structure of the TrwM/VirB3-TrwE/VirB10 106 
complex from R388 T4SS has recently revealed the T4SS architecture (12). 107 
However, the internal channel, the dimensions of which might give a clue on the 108 
folding state of the substrate during transport, has not been identified yet. In this 109 
report, we have studied the requirements for the substrate translocation by the R388 110 
conjugative T4SS. We show that the T4SS substrates have to be unfolded in order to 111 
be translocated into recipient cells.   112 
 113 
Results 114 
The overall aim of this study is to investigate whether transport of the relaxase 115 
requires unfolding of the protein.  In order to answer this question, our strategy was 116 
to fuse unfolding-resistant proteins or protein modules of various sizes to TrwC and 117 
test if they can be transported into recipient cells. We first sought to test this by 118 
directly monitoring the transport of the protein itself during conjugation using the 119 
previously described Cre recombinase reporter assay for translocation (CRAfT 120 
(35,36)). 121 
 122 
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Establishing a translocation assay of the TrwC relaxase based on the CRAfT assay    123 
Briefly, the recipient strain contains a chloramphenicol resistance gene 124 
interrupted by a tetracyclin resistance cassette flanked by loxP sites. Therefore, the 125 
strain is tetracyclin resistant, but upon Cre recombination becomes tetracyclin 126 
sensitive and chloramphenicol resistant. The transfer of Cre recombinase-substrate 127 
fusion can be measured by measuring the change in antibiotic resistance of recipient 128 
cells upon conjugation. We used a two-plasmid system composed of a plasmid 129 
containing R388 oriT, termed pRSF-oriT, and a plasmid encoding relaxosome 130 
components (TrwA, TrwB, and TrwC) and T4SS, termed pBAD-ABC-T4SS. This two-131 
plasmid system typically resulted in 60-80% recipients acquiring the oriT plasmid 132 
(transconjugants) in our conjugation assay. 133 
We first fused the Cre recombinase at different locations within the TrwC 134 
substrate and tested which construct retains functionality (both in plasmid 135 
conjugation and Cre recombination). Cre recombinase was fused to the TrwC N-136 
terminus (termed Cre-TrwC), TrwC C-terminus (termed TrwC-Cre) and in between 137 
the relaxase and helicase domains (termed R-Cre-H) (Fig. 1A). Given the fact that 138 
the first methionine (Met1) of the N-terminal relaxase domain is located at the center 139 
of the relaxase structure and participates in DNA binding, together with Leu2, His4, 140 
Met5, and Val6 (24), there was a possibility that the N-terminal fusion might abolish 141 
oriT binding and/or nicking, and therefore conjugation. Nevertheless, TrwC transfer 142 
without DNA transfer has previously been observed (37) and, thus, we proceeded 143 
with making and testing all three Cre fusions of TrwC, even the N-terminal one.  144 
Cre recombinase retained functionality in all three fusions (Fig. 1B). 145 
Surprisingly, conjugation level of all three fusions was high, even for the N-terminal 146 
fusion; however, protein transfer was detected only in the case of Cre-TrwC and R-147 
Cre-H (Fig. 1C). Since TrwC-Cre is not transported into the recipient cells at 148 
detectable levels, the high conjugation efficiency observed with this construct is most 149 
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likely due to a fraction of TrwC lacking the C-terminal Cre fusion - a result of 150 
proteolytic degradation within the cell. 151 
Cre-TrwC displays a high level of conjugation, indicating that N-terminal 152 
fusions of TrwC might be active in DNA transport after all. We therefore tested 153 
purified TrwC with and without N-terminal fusions in an oriT nicking assay. As shown 154 
in Fig. 2, whereas TrwC-His6 formed a covalent linkage with pUC-oriT plasmid, we 155 
did not detect any mGFP-TrwC, or even GA-TrwC (TrwC with an additional N-156 
terminal glycine and alanine residue) covalently bound to oriT. Since even only two 157 
additional N-terminal residues can abolish TrwC activity, the source of TrwC protein 158 
that is functional in conjugation is most likely wild type TrwC co-expressed starting 159 
from the original start codon. The linker sequence between Cre and TrwC that lies 160 
just upstream of the TrwC start codon is rich in GG nucleotides, possibly acting as a 161 
ribosome-binding site. In conclusion, both N-terminal and C-terminal fusions abolish 162 
TrwC transport and/or activity.  163 
Unlike the N-terminal and C-terminal Cre fusions, which can both apparently 164 
yield a Cre-less, wild-type version of the protein (see above), the internal Cre fusion 165 
construct cannot undergo modifications yielding wild-type TrwC. Indeed, separated 166 
relaxase and helicase domains that could arise by proteolytic degradation are not 167 
functional (27,38). Therefore, the measured conjugation efficiency of R-Cre-H 168 
reflects the activity of the full-length protein. R-Cre-H also showed almost two orders 169 
of magnitude higher level of protein translocation in the CRAfT experiment in 170 
comparison to Cre-TrwC (Fig. 1C). Since Cre-TrwC is not functional in oriT nicking, 171 
the protein is in this case transported without being attached to the T-strand as 172 
described in Draper et al. 2005 (37). In order to test if oriT binding is the reason for 173 
higher protein translocation of R-Cre-H, we repeated the CRAfT assay but this time 174 
excluding the pRSF-oriT plasmid. Surprisingly, we detected higher protein transport 175 
in the absence of oriT plasmid than in its presence (Fig. 1D). This indicates that the 176 
Cre recombination in recipient cells might be affected by the presence of the T-177 
 o
n
 February 13, 2018 by BIRKBECK CO
LLEG
E
http://jb.asm.org/
D
ow
nloaded from
 
  Trokter and Waksman (2017) 
 Page 8 
strand, possibly due to a competition with the TrwC helicase activity along the T-178 
strand.  179 
 180 
Substrate unfolding is a pre-requirement for translocation through T4SS  181 
Next, we chose the N-terminal fusions to test the extent of substrate unfolding 182 
required for its transport through T4SS. We fused a set of unfoldable (this word is 183 
used here to mean “that can be unfolded”) and unfolding-resistant (that cannot be 184 
unfolded) proteins between Cre and TrwC (Fig. 3A) and tested if they can be 185 
transported into recipient cells. With Cre recombinase positioned at the very N-186 
terminus and TrwC translocation signal at the very C-terminus, these constructs 187 
allow us to detect the transport of only full-length proteins. Ubiquitin (Ub; 8 kDa) and 188 
GFP (27 kDa) have been reported to be resistant to unfolding, whereas the ubiquitin 189 
mutant UbI3G,I13G (Ub3,13) served as the unfoldable protein control (34,39). We first 190 
tested the Cre recombinase activity of these constructs. Cre recombinase was 191 
functional in all fusions tested (Fig. 3B).  192 
When tested in the CRAfT assay, the protein construct containing the 193 
unfoldable fusion, the ubiquitin mutant (Ub3,13), was transported into recipient cells at 194 
very high levels (~10% recipient cells underwent recombination; Fig. 3C). In 195 
comparison, its wild-type ubiquitin counterpart was transported at about five orders of 196 
magnitude lower level, similar to the construct containing mGFP. These data clearly 197 
demonstrate that the conjugative T4SS substrate, the relaxase protein, has to be 198 
unfolded in order to pass through the T4SS channel.  199 
 200 
Relaxase constructs that block substrate translocation in the native plasmid 201 
Experiments above were conducted using an artificial two-plasmid system 202 
reporting on protein transport to the recipient cell. We sought next to monitor the 203 
nucleoprotein substrate transport through conjugative T4SS using the native R388 204 
plasmid. We also sought to expand the range of fusion proteins probed. For this 205 
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purpose, it was necessary to generate a modified protein substrate that is fully 206 
functional. We therefore generated three different sets of relaxase constructs and 207 
tested their functionality. For these experiments, we directly modified TrwC in the 208 
wild-type R388 plasmid. Since N-terminal fusions abolish oriT nicking activity, we 209 
tested if duplicating the relaxase domain in front of the N-terminal fusion can recover 210 
relaxase activity (Fig. 4A left). In order to avoid expression of the wild-type TrwC from 211 
its original start codon, the first methionine in the second relaxase domain was 212 
deleted. Indeed, the addition of the relaxase domain in front of the unfoldable 213 
ubiquitin fusion resulted in wild-type levels of relaxase activity (Fig. 4A right). The 214 
high conjugation efficiency of this construct is not the result of proteolysis of mutant 215 
ubiquitin (Fig. S1). Replacing an unfoldable fusion with an unfolding-resistant one 216 
efficiently blocks the substrate transport, resulting in more than two orders of 217 
magnitude lower conjugation efficiency (Fig. 4A right).  218 
Equivalently, an attempt was made to recover the activity of C-terminal 219 
fusions by adding another helicase domain (H) to the C-terminus of a TrwC-fusion 220 
(Fig. 4B left). In this case, the duplication of the helicase domain did not completely 221 
restore the wild-type level of relaxase activity (Fig. 4B right), potentially due to the 222 
suboptimal position of the translocation signal (e.g. too large a distance between the 223 
relaxase and the functional translocation signal). The difference in the conjugation 224 
efficiency between the unfolding-resistant and unfoldable ubiquitin construct is lower 225 
than for the constructs with the duplicated relaxase. The observed conjugation 226 
efficiency of TrwC-Ub/mGFP-H constructs might be a result of either co-expression 227 
of the wild-type TrwC (as a result of either degradation and/or premature translation 228 
termination) or suboptimal folding of ubiquitin and mGFP at the TrwC C-terminus. 229 
  Finally, we tested the activity of TrwC containing internal fusions between its 230 
relaxase and helicase domain (Fig. 4C left). Internal fusion with Ub3,13 retains wild-231 
type level of activity (Fig. 4C right). Unfolding-resistant (Ub or mGFP) fusions 232 
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efficiently blocked substrate transport, with conjugation efficiencies of more than 233 
three orders of magnitude lower than its unfoldable counterpart. 234 
 We note that in all unfolding-resistant variants tested, a very low residual level 235 
of translocation/transfer is observed, likely due to a small fraction of these proteins 236 
being less resistant to unfolding, due to defects in their folded state. 237 
 238 
Conclusion 239 
Secretion in bacteria is a critical process in pathogenesis and inter-bacterial 240 
competition in many bacterial pathogens. Bacteria have evolved a diversity of 241 
specialized secretion systems to export a wide range of substrates, including small 242 
molecules, proteins and DNA, across the cell envelope (3). Some secretion systems, 243 
such as T2SS (29) and chaperone-usher pathway (30,31), transport fully folded 244 
protein substrates, whereas some can transport only unfolded substrates (e.g. T1SS 245 
(32) and T3SS (33,34)). In this report we demonstrate that conjugative T4SS 246 
substrates, relaxases, have to undergo unfolding in order to be transported through 247 
the T4SS channel. Comparison of translocation frequencies of unfolding-resistant 248 
TrwC fusions and their unfoldable counterparts clearly demonstrated that both TrwC 249 
alone and TrwC covalently attached to the T-strand are transported into recipient 250 
cells in an unfolded state. In that respect, conjugative T4SSs works in a similar 251 
manner as effector only-transporting T4SSs such as that of the bacterial pathogen 252 
Legionella pneumophila (46). 253 
T1SS substrates fold upon binding of calcium, which is low in the bacterial 254 
cytosol, but high in the extracellular space, therefore it is generally assumed that 255 
T1SS substrates adopt their folded conformation only after secretion into the 256 
extracellular space. Conjugative relaxases are clearly folded prior to their 257 
translocation, as they are fully functional when expressed in a bacterial cell. Which 258 
enzyme/unfoldase is responsible for T4SS substrate unfolding remains unclear. In 259 
case of T3SS, a dedicated hexameric ATPase has a critical function in substrate 260 
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recognition and unfolding in an ATP-dependent manner (33). T4SS, on the other 261 
hand, is energized by three distinct hexameric ATPases: VirB4, VirB11 and T4CP. 262 
T4CP is an integral membrane protein that interacts with the relaxase and accessory 263 
proteins and recruits the transfer intermediate to the T4SS translocation machinery. 264 
T4CP ATPase activity is not required for the recruitment (41). However, ATPase 265 
activity of all three ATPases is essential for nucleoprotein transport (41). VirB4 is an 266 
integral part of the T4SS inner-membrane complex (IMC) and is located mainly in the 267 
cytoplasm. VirB11 is a cytoplasmic ATPase that interacts with T4CP and VirB4. 268 
Apart from being essential for substrate transport, VirB4 and VirB11 are required for 269 
T4SS pilus assembly. Due to their several roles that are essential for the T4SS 270 
function, it is difficult to predict which ATPase is responsible for substrate unfolding.  271 
 The CRAfT experiments performed here also revealed that an N-terminal 272 
fusion might abolish a relaxase function (Fig. 1). TrwC oriT nicking activity was 273 
sensitive to addition of only two amino acids at its N-terminus (Fig. 2). The crystal 274 
structure of TrwC relaxase domain in complex with its cognate DNA at oriT showed 275 
that first five TrwC residues participate in binding DNA (24). The N-terminal 276 
methionine alone forms multiple interactions with DNA. Its side chain is trapped in a 277 
hydrophobic cage formed by a sharp U-turn of the T-strand DNA, whereas its amino 278 
group forms a hydrogen bond with the DNA. Therefore, addition of any amino acids 279 
to the relaxase N-terminus might perturb the oriT binding and result in an inactive 280 
protein.   281 
Finally, we showed here that although the terminal fusions abolish the 282 
relaxase activity, it is possible to modify the relaxase in different ways in order to 283 
preserve the functionality of its domains. Placing a fusion internally or duplicating a 284 
domain can recover a relaxase activity, and unfolding-resistant fusions can be used 285 
to efficiently block the substrate transport. This will be particularly important for 286 
deciphering the complete mechanism of T4SS substrate translocation. T4SS 287 
substrates modified with unfolding-resistant fusions at appropriate locations could be 288 
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used as a tool to efficiently trap the substrate during translocation. Structural studies 289 
of the T4SS in complex with the substrate trapped within will allow defining the 290 
substrate translocation path and T4SS conformational changes necessary for 291 
translocation. Deciphering the details of T4SS translocation mechanism will be vital 292 
to facilitate development of new therapies against multidrug-resistant pathogenic 293 
bacteria. 294 
 295 
Methods 296 
Molecular biology 297 
oriT and expression plasmids used in this study are described in Table S1. 298 
Primer sequences are shown in Table S2. DNA fragments used for cloning were 299 
amplified using Phusion High-Fidelity DNA Polymerase (NEB) following 300 
manufacturer’s instructions. Restriction enzymes were obtained from NEB. Unless 301 
otherwise stated, antibiotic concentrations used were: kanamycin (Km) 30 μg/ml, 302 
ampicillin (Amp) 100 μg/ml, tetracycline (Tc) 10 μg/ml, chloramphenicol (Cm) 10 303 
μg/ml, streptomycin (Sm) 25 μg/ml, and trimethoprim (Tmp) 10 μg/ml.  304 
pRSF-oriT was generated by ligation (Rapid DNA ligation Kit, Roche) of 305 
amplified oriT and pRSFDuet-1 vector digested with BssHII restriction enzyme. pUC-306 
oriT was generated by ligation of amplified oriT and pUC18 vector digested with 307 
HindIII-HF and SacI-HF restriction enzymes.  308 
Unless otherwise stated, all plasmids used in this study were generated by 309 
seamless cloning using In-Fusion HD Cloning Kit (Clontech). In most cases, the 310 
constructs were generated by fusing two PCR fragments. In some cases (described 311 
below), the constructs were generated by fusing a PCR fragment and a linearized 312 
vector. pBAD-trwN/virB1-trwE/virB10Strep-trwD/virB11 was cloned by amplifying 313 
trwD/virB11 and inserting it into pBAD-trwN/virB1-trwE/virB10Strep plasmid (12) which 314 
was linearized using BstBI restriction enzyme. pBAD-ABC-T4SS was cloned by 315 
amplifying trwABCHis and inserting it into pBAD-trwN/virB1-trwE/virB10Strep-316 
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trwD/virB11 plasmid which was linearized using NcoI restriction enzyme. All pBAD-317 
ABC-T4SS constructs encoding modified TrwC were cloned in the same way (by 318 
amplifying ABC and inserting into linearized pBAD-trwN/virB1-trwE/virB10Strep-319 
trwD/virB11 plasmid).   320 
TrwC internal fusions were inserted into an unstructured region between the 321 
relaxase and helicase domains (between residue 312 and 313). The TrwC secondary 322 
structure was predicted using PSIPRED v3.3 (http://bioinf.cs.ucl.ac.uk/psipred/).  323 
Ubiquitin mutant was generated using QuikChange Lightning Multi Site-324 
Directed Mutagenesis Kit (Agilent Technologies) following manufacturer’s 325 
instructions. Cre active site mutant was generated using QuikChange Lightning Site-326 
Directed Mutagenesis Kit (Agilent Technologies) following manufacturer’s 327 
instructions. 328 
 329 
Modification of the wild-type R388 plasmid 330 
Modified R388 plasmids used in this study are described in table S3. The 331 
R388 plasmid was modified using recombineering method following the multicopy 332 
plasmid modification protocol (42,43). The two-step seamless method using the cm-333 
sacB selection cassette was used to create precise genetic changes without 334 
otherwise altering the plasmid. The cm-sacB cassette is used for positive/negative 335 
selection; it can be selected either for (by chloramphenicol resistance) or against 336 
(sucrose sensitivity). In the first recombineering step, the sequence to be modified is 337 
replaced with the cm-sacB cassette; the cassette is then replaced with the desired 338 
alteration in the second recombineering event.  339 
The bacterial strain containing the defective λ prophage, SW102 (44), and the 340 
plasmid containing cm-sacB cassette, pEL04, were obtained from NCI-Frederick. 341 
PCR products used for homologous recombination contained at each end on 342 
average about 200 base pairs of flanking homology to the desired region on the 343 
plasmid. For this purpose, PCR templates were first generated using In-Fusion HD 344 
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Cloning Kit. We first made the templates for the second recombineering step by 345 
modifying TrwC encoded on the pBAD-ABC vector (see tables S1 and S2). The 346 
templates for the first recombineering step were then prepared by replacing a desired 347 
TrwC modification on a relevant pBAD-ABC vector (encoding relevant modified 348 
TrwC) with the cm-sacB cassette. PCR products were amplified from linearized 349 
templates using Phusion High-Fidelity DNA Polymerase (NEB), digested with DpnI, 350 
and purified using MinElute Gel Extraction Kit (Qiagen). The details of the templates 351 
and PCR products are given below.  352 
To generate R388 plasmid encoding TrwC with a fusion protein in between 353 
the relaxase (R) and helicase domains (H), R388_R-Ub/Ub3,13/mGFP-H, the template 354 
for the first recombineering step was generated by replacing the relaxase and the 355 
first part of helicase domain in pBAD-ABCHis plasmid with cm-sacB cassette, 356 
generating pBAD-AB_Cm-SacB-H plasmid. In the first recombineering step, the PCR 357 
fragment containing B_Cm-SacB-H was amplified from pBAD-AB_Cm-SacB-H 358 
plasmid and used to modify the wild-type R388. In the second recombineering step, 359 
the PCR fragment containing B_R-Ub/Ub3,13/mGFP-H was amplified from pBAD-360 
AB_R-Ub/Ub3,13/mGFP-H plasmid and used to modify R388_B_Cm-SacB-H.  361 
To generate wild-type R388 plasmid encoding TrwC with duplicated domains, 362 
four recombineering steps were necessary. The two-step approach, using a PCR 363 
product with duplicated domain sequences in the second step, generated R388 364 
plasmid encoding wild-type TrwC. This is because the recombineering occurs 365 
through a fully ssDNA intermediate of the PCR fragment (45), most likely resulting in 366 
recombination of the duplicated domains, generating the wild-type protein.  367 
To generate R388 plasmid encoding TrwC with duplicated relaxase domains 368 
(R) and a fusion protein in between, R388_R-Ub/Ub3,13/mGFP-TrwC, following PCR 369 
fragments were generated. For the first recombineering step, the PCR fragment 370 
encoding B_Cm-SacB-H was amplified from pBAD-AB_Cm-SacB-H plasmid. For the 371 
second step, the PCR fragment encoding B_R-His6-Ub/Ub
3,13/mGFP-H was amplified 372 
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from pBAD-AB_R-His6-Ub/Ub
3,13/mGFP-H plasmid. For the third step, the PCR 373 
fragment encoding Ub/Ub3,13/mGFP-Cm-SacB-H was amplified from pBAD-AB_R-374 
His6-Ub/Ub
3,13/mGFP-Cm-SacB-H plasmid. For the fourth step, the PCR fragment 375 
encoding Ub/Ub3,13/mGFP-TrwC was amplified from pBAD-AB_R-His6-376 
Ub/Ub3,13/mGFP-TrwC plasmid. 377 
To generate R388 plasmid encoding TrwC with duplicated helicase domains 378 
(H) and a fusion protein in between, R388_TrwC-Ub/Ub3,13/mGFP-H, following PCR 379 
fragments were generated. For the first step, the PCR fragment encoding H-Cm-380 
SacB-B11 was amplified from pBAD-ABC-Cam-SacB-trwD/virB11 plasmid. 381 
TrwD/VirB11 is the protein encoded downstream of TrwC in the wild-type R388 382 
plasmid. For the second step, the PCR fragment encoding H-Ub/Ub3,13/mGFP-His6-383 
B11 was amplified from pBAD-ABC-Ub/Ub3,13/mGFP-His6-trwD/virB11 plasmid. For 384 
the third step, the PCR fragment encoding Ub/Ub3,13/mGFP-Cm-SacB-trwD/virB11 385 
was amplified from pBAD-ABC-Ub/Ub3,13/mGFP-Cm-SacB-trwD/virB11 plasmid. For 386 
the fourth step, the PCR fragment encoding Ub/Ub3,13/mGFP-H-His6-trwD/virB11 was 387 
amplified from pBAD-AB_R-Ub/Ub3,13/mGFP-H-His6-trwD/virB11 plasmid. 388 
Electrocompetent SW102 cells were prepared in the following way. 1.5 ml of 389 
SW102 cells grown overnight at 30°C were diluted in 75 ml LB medium and grown 390 
shaking at 32°C until reaching OD600 of 0.5. The λ recombination genes were 391 
induced by placing the flask into a 42°C shaking water bath for 15 min. The flask was 392 
then cooled in the ice-water slurry and the electrocompetent cells were prepared by 393 
washing the cells twice with 40 ml ice-cold distilled water and resuspending in 200 μl 394 
distilled water. 50 μl cells were electroporated with 60 ng plasmid and 100-150 ng 395 
purified PCR fragment and shaken for 2 hours at 30°C in 1 ml LB. After 2h, 9 ml of 396 
LB medium containing 12.5 μg/ml chloramphenicol (in the case of first 397 
recombineering step) or 10 μg/ml trimethoprim (in the case of second 398 
recombineering step) was added and the culture was grown overnight shaking at 399 
30°C. The following morning, the plasmid was isolated from the culture using 400 
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QIAprep Spin Miniprep Kit (Qiagen), transformed into electrocompetent TOP10 cells, 401 
and recombined plasmid was selected on LB agar plates containing chloramphenicol 402 
(in the case of first recombineering step) or trimethoprim and 6% sucrose and lacking 403 
NaCl (in the case of second recombineering step). Several Cm-resistant and 404 
sucrose-sensitive colonies (in the case of first recombineering step) or Cm-sensitive 405 
and sucrose- and Tmp-resistant colonies (in the case of second recombineering 406 
step) were grown and recombinant plasmids isolated and sequenced.  407 
 408 
Cre recombination test  409 
Prior to the CRAfT experiments described below, Cre recombinase activity for each 410 
Cre fusion construct was tested. CSH26Cm::LTL cells (TcR; Lang et al. 2010) 411 
carrying pBAD-ABC (AmpR) with or without modified TrwC (as indicated in Results) 412 
were grown overnight in LB medium containing tetracycline, ampicillin, and 0.4% 413 
glucose. 125 μl of the overnight culture were pelleted and resuspended in 5 ml LB 414 
medium containing ampicillin. The culture was grown at 37°C until reaching OD600 of 415 
0.6. The cells were then put on ice. Recombinants were selected by plating serial 416 
dilutions on LB agar plates containing chloramphenicol, and total cell counts were 417 
determined as the sum of cells growing on tetracycline plates and cells growing on 418 
chloramphenicol plates. There were no cells growing on tetracycline and 419 
chloramphenicol plates. The recombination frequencies are calculated as 420 
recombinants per total amount of cells.  421 
 422 
Cre recombinase reporter assay for translocation (CRAfT) 423 
The Cre fusion reporter assay was adapted from Lang et al. 2010. An overnight 424 
culture of TOP10 donor cells carrying pRSF-oriT (KmR) and/or pBAD-ABC-T4SS 425 
(AmpR) with or without modified TrwC (as indicated in Results) was diluted 20x in LB 426 
medium containing appropriate antibiotics and grown at 37°C until reaching OD600 of 427 
0.6. The cultures were then induced with 0.08% (vol/vol) arabinose for 1 hour. In 428 
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parallel, an overnight culture of CSH26Cm::LTL recipient cells (TcR) was diluted 40x 429 
in LB medium and grown at 37°C. Donors corresponding to OD of 1 and recipients 430 
corresponding to OD of 0.1 were spun and resuspended in 50 μl LB. The mixture 431 
was pipetted onto a filter paper (MF-Millipore Membrane, mixed cellulose esters, 432 
0.45 μm) lying on top of an LB plate that was beforehand well dried. The filter was 433 
incubated at 37°C for 2.5 hours and then recovered into an Eppendorf tube. The cells 434 
were washed off the filter by adding LB medium and gently vortexing the tube. 435 
Recombinants were selected by plating serial dilutions on LB agar plates containing 436 
chloramphenicol, and when pRSF-oriT was present transconjugants were selected 437 
on LB agar plates containing kanamycin and tetracycline. Recipient cell counts were 438 
determined as the sum of cells growing on tetracycline plates and cells growing on 439 
chloramphenicol plates. No cells grew on tetracycline and chloramphenicol plates. 440 
The conjugation and protein translocation frequencies are calculated as 441 
transconjugants or recombinants per recipient respectively.  442 
 443 
TrwC purification 444 
A culture of E. coli TOP10 cells carrying pBAD-ABCHis (Amp
R) was grown at 445 
37°C from a single colony until reaching OD600 of 0.6. Protein expression was 446 
induced with 0.08% (vol/vol) arabinose, and the culture was incubated overnight at 447 
18°C shaking at 200 rpm. Cells were harvested and resuspended in ice-cold 448 
resuspension buffer [50 mM HEPES, 15 mM imidazole, pH 7.8 at 4°C] supplemented 449 
with 0.5 mg/ml lysozyme and protease inhibitors (Complete EDTA-free; Roche). After 450 
resuspension, the lysate was supplemented with 5 mM MgCl2 and 25 U/ml 451 
benzonase (Merck Millipore) and incubated for 15 min on ice. The lysate was then 452 
supplemented with 250 mM NaCl and passed through a high-pressure homogenizer 453 
(Emulsiflex-C5; Avestin). The cell lysate was clarified by centrifugation at 100,000 g 454 
for 30 min at 4 °C and applied to a 5-mL HiTrap Chelating HP column (GE 455 
Healthcare) loaded with cobalt ions and equilibrated with wash buffer [50 mM 456 
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HEPES, 250 mM NaCl, 20 mM imidazole, pH 7.8 at 4°C]. The column was then 457 
washed extensively first with wash buffer followed by high-salt buffer A [50 mM 458 
HEPES, 500 mM NaCl, pH 7.8 at 4°C] and finally re-equilibrated with wash buffer. 459 
The protein was eluted with 10 column volumes of linear imidazole gradient [A: wash 460 
buffer; B: 50 mM HEPES, 200 mM NaCl, 500 mM imidazole, pH 8.0 at 4°C]. The 461 
eluted protein was applied to a 5-mL HiTrap SP HP column (GE Healthcare) 462 
equilibrated with low-salt buffer [50 mM HEPES, 250 mM NaCl, pH 7.8 at 4°C]. The 463 
protein was eluted with 10 column volumes of linear salt gradient [A: low-salt buffer; 464 
B: 50 mM HEPES, 1 M NaCl, pH 7.8 at 4°C]. The eluted protein was further purified 465 
by gel filtration using a Superdex 200 10/300 GL column equilibrated in gel-filtration 466 
buffer [50 mM HEPES, 500 mM NaCl, pH 7.8 at 4°C]. The protein concentration was 467 
determined by measuring the absorbance at 280 nm and using a molar extinction 468 
coefficient calculated from its primary sequence (Expasy; 469 
http://expasy.org/tools/protparam.html). Proteins were supplemented with glycerol to 470 
a final concentration of 20% (vol/vol), flash-frozen, and stored at -80°C. 471 
mGFP-TrwC and GA-TrwC (TrwC with additional two residues, glycine and 472 
alanine, at its N-terminus) were purified as described above for TrwC-His6 with 473 
following modifications. pETZt-mGFP-trwC and pETZt-trwC (KnR) were used to 474 
transform E. coli BL21 Star (DE3) cells. Protein expression was induced with 0.1 mM 475 
isopropylthio-β-galactoside (IPTG). In the case of GA-TrwC, following the ion-476 
exchange step, the N-terminal His6-Z tag was cleaved off during an overnight 477 
incubation at 4°C with His6–tagged TEV protease (1 mg of protease per 30 mg of 478 
substrate). The mixture was simultaneously dialyzed into wash buffer B [50 mM 479 
HEPES, 500 mM NaCl, 20 mM imidazole, pH 7.8 at 4°C]. Cleaved His6-Z tag and the 480 
protease were removed by rebinding to a cobalt-charged HiTrap chelating HP 481 
column equilibrated with wash buffer B. The flow-through (containing cleaved 482 
proteins) was concentrated and further purified by gel filtration as described above.   483 
 484 
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oriT nicking assay 485 
To test DNA nicking by different TrwC constructs, pUC-oriT was mixed with 486 
either TrwC-His6, GA-TrwC, or mGFP-TrwC and incubated for 30 min at 37°C. The 487 
final mixture contained 40 nM pUC-oriT and 40, 80 or 160 nM TrwC, and the final 488 
binding buffer contained 30 mM HEPES pH 7.6 at 25°C, 100 mM NaCl, and 5 mM 489 
MgCl. After incubation, reaction mixtures were supplemented with NuPAGE LDS 490 
Sample Buffer (ThermoFisher Scientific) and EDTA at the final concentration of 1x 491 
and 5 mM, respectively. The samples were heated at 95°C for 5 min and loaded onto 492 
a NuPAGE Novex 4-12% Bis-Tris gel (ThermoFisher Scientific). Following SDS-493 
PAGE, the gel was stained with SYPRORuby Protein Gel Stain (ThermoFisher 494 
Scientific) following manufacturer’s instructions. TrwC constructs were visualized 495 
using a FLA-3000 fluorescent imaging scanner (FujiFilm).   496 
To test its specificity of DNA nicking, TrwC-His6 was mixed with either pUC-497 
oriT or pUC18 plasmid and incubated for 30 min at 37°C. The final mixture contained 498 
50 or 100 nM TrwC-His6 and 20 nM plasmid, and the final binding buffer contained 499 
30 mM HEPES pH 7.6 at 25°C, 100 mM NaCl, 5 mM MgCl2, and 4% glycerol. 500 
After incubation, the samples were further processed as described above.  501 
 502 
R388 conjugation assay 503 
An overnight culture of TOP10 donor cells (SmR) carrying R388 plasmid (TmpR) with 504 
wild-type or modified TrwC (as indicated in Results) was diluted 20x in LB medium 505 
and grown at 37°C until reaching OD of 0.6. In parallel, an overnight culture of 506 
CSH26Cm::LTL recipient cells (TcR) was diluted 30x in LB medium and grown at 507 
37°C. Donors corresponding to OD of 0.3 and recipients corresponding to OD of 0.6 508 
were spun and resuspended in 50 μl LB. This OD ratio corresponded to 3:1 509 
recipients per donor. The mixture was pipetted onto a filter paper as described for the 510 
CRAfT experiments and incubated at 37°C for 1.5 hours. The filter was then placed 511 
into an Eppendorf tube and cells were washed off by addition of LB medium and 512 
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gentle vortexing. Transconjugants were selected on LB agar plates containing 513 
tetracycline and trimethoprim. Donor cell counts were determined with streptomycin 514 
and trimethoprim, and recipient cell counts were determined with tetracycline. The 515 
conjugation frequencies are calculated as transconjugants per donor.  516 
 517 
Data availability 518 
All relevant data are available from the authors upon request. 519 
 520 
Figure legends 521 
 522 
Figure 1. Establishing Cre recombinase reporter assay for translocation of R388 523 
T4SS substrates.  524 
(A) Scheme of TrwC constructs with Cre recombinase fusion at different positions.  525 
(B) Recombination efficiency of Cre recombinase fused to the TrwC N-terminus (Cre-526 
TrwC), TrwC C-terminus (TrwC-Cre) and in between the relaxase and helicase 527 
domains (R-Cre-H) when expressed in recipient cells. Values represent the mean ± 528 
SEM of four experiments. Unpaired t-test showed no significant difference between 529 
recombination efficiencies of Cre-TrwC, R-Cre-H, and TrwC-Cre (P > 0.05). 530 
(C) Conjugation and protein translocation efficiency of cells carrying pRSF-oriT and 531 
pBAD-ABC-T4SS plasmid encoding modified TrwC as indicated. The efficiencies are 532 
expressed as a fraction of recipient cells that acquired pRSF-oriT plasmid 533 
(transconjugants) and TrwC fusion protein (recombinants), respectively. Values 534 
represent the mean ± SEM of three experiments. Statistically significant differences 535 
(unpaired t test) between wild-type and Cre fusion construct conjugation frequencies 536 
are indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 537 
(D) The comparison of TrwC translocation in the presence (red bars) or absence 538 
(grey bars) of pRSF-oriT plasmid. The protein translocation efficiencies are 539 
expressed as a fraction of recipient cells that acquired indicated TrwC fusion protein. 540 
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Values represent the mean ± SEM of four experiments. Statistically significant 541 
differences (unpaired t test) between translocation frequencies in the presence or 542 
absence of oriT are indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 543 
 544 
Figure 2. N-terminal fusions abolish TrwC nicking of oriT.  545 
(A) SYPRORuby-stained SDS gel showing purified TrwC-His6, GA-TrwC (glycine-546 
alanine-TrwC), and mGFP-TrwC free or covalently bound to pUC-oriT. 40, 80, or 160 547 
nM TrwC constructs were incubated at 37°C for 30 min with 40 nM pUC-oriT before 548 
the nicking reaction was stopped by adding SDS sample buffer and EDTA and 549 
heating at 95°C.  550 
(B) TrwC-His6 nicks oriT specifically. 50 nM (lane 1,3) or 100 nM (lane 2,4) TrwC-His6 551 
was incubated with either pUC-oriT or pUC18 plasmid (20 nM) as indicated at 37°C 552 
for 30 min before the reaction was stopped by adding SDS sample buffer and EDTA 553 
and heating at 95°C. 554 
 555 
Figure 3. TrwC unfolding is necessary for its translocation through T4SS.  556 
(A) Scheme of TrwC constructs with N-terminal Cre recombinase followed by an 557 
unfoldable (Ub3,13) or unfolding-resistant (Ub, mGFP) fusion.  558 
(B) Recombination efficiency of Cre recombinase fused to the N-terminus of the 559 
indicated protein followed by TrwC when expressed in recipient cells. Values 560 
represent the mean ± SEM of three experiments. Statistically significant differences 561 
(unpaired t test) between recombination efficiencies of Cre-TrwC and constructs with 562 
an additional fusion are indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 563 
(C) Protein translocation efficiency of cells carrying pBAD-ABC-T4SS plasmid 564 
encoding modified TrwC as indicated. Values represent the mean ± SEM of four 565 
experiments. Statistically significant differences (unpaired t test) between protein 566 
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translocation efficiencies of Cre-TrwC and constructs with an additional fusion are 567 
indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 568 
 569 
Figure 4. Conjugation of TrwC fusions in native R388 plasmid. 570 
(A) Duplicated relaxase domain recovers oriT nicking activity of TrwC with N-terminal 571 
fusion. (Left) Scheme of TrwC constructs with duplicated relaxase domain and 572 
indicated fusion protein (termed R-X-TrwC, where X represents Ub3,13, Ub, or 573 
mGFP). (Right) Conjugation efficiency of cells carrying R388 plasmid encoding 574 
modified TrwC as indicated. Values represent the mean ± SEM of three experiments. 575 
Statistically significant differences (unpaired t test) between wild-type and fusion 576 
construct conjugation frequencies are indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 577 
0.001. 578 
 579 
(B) Conjugation efficiency of TrwC-fusion-helicase constructs. (Left) Scheme of TrwC 580 
constructs with indicated fusion protein and duplicated helicase domain (termed 581 
TrwC-X-H, where X represents Ub3,13, Ub, or mGFP). (Right) Conjugation efficiency 582 
of cells carrying R388 plasmid encoding modified TrwC as indicated. Values 583 
represent the mean ± SEM of three experiments. Statistically significant differences 584 
(unpaired t test) between conjugation frequencies of indicated pairs of constructs are 585 
shown. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.  586 
 587 
(C) TrwC relaxase and helicase domains retain their functionality after being 588 
separated by an internal fusion. (Left) Scheme of TrwC constructs with indicated 589 
internal fusion (termed R-X-H, where X represents Ub3,13, Ub, or mGFP). (Right) 590 
Conjugation efficiency of cells carrying R388 plasmid encoding modified TrwC as 591 
indicated. Values represent the mean ± SEM of three experiments. Statistically 592 
significant differences (unpaired t test) between wild-type and fusion construct 593 
conjugation frequencies are indicated. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 594 
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